These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 21178122

  • 1. Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia.
    Wu N, Sarna LK, Siow YL, O K.
    Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R635-43. PubMed ID: 21178122
    [Abstract] [Full Text] [Related]

  • 2. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors.
    Woo CW, Siow YL, Pierce GN, Choy PC, Minuk GY, Mymin D, O K.
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1002-10. PubMed ID: 15644462
    [Abstract] [Full Text] [Related]

  • 3. Physiological feedback regulation of cholesterol biosynthesis: Role of translational control of hepatic HMG-CoA reductase and possible involvement of oxylanosterols.
    Ness GC.
    Biochim Biophys Acta; 2015 May; 1851(5):667-73. PubMed ID: 25701719
    [Abstract] [Full Text] [Related]

  • 4. Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding.
    Wu N, Sarna LK, Hwang SY, Zhu Q, Wang P, Siow YL, O K.
    Biochim Biophys Acta; 2013 Oct; 1832(10):1560-8. PubMed ID: 23651731
    [Abstract] [Full Text] [Related]

  • 5. The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet.
    Chang XX, Yan HM, Xu Q, Xia MF, Bian H, Zhu TF, Gao X.
    Lipids Health Dis; 2012 Jul 04; 11():86. PubMed ID: 22762542
    [Abstract] [Full Text] [Related]

  • 6. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
    Ness GC, Holland RC, Lopez D.
    Exp Biol Med (Maywood); 2006 May 04; 231(5):559-65. PubMed ID: 16636304
    [Abstract] [Full Text] [Related]

  • 7. Dietary cholesterol regulates hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in rats primarily at the level of translation.
    Chambers CM, Ness GC.
    Arch Biochem Biophys; 1998 Jun 15; 354(2):317-22. PubMed ID: 9637742
    [Abstract] [Full Text] [Related]

  • 8. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
    Ness GC, Zhao Z, Keller RK.
    Arch Biochem Biophys; 1994 Jun 15; 311(2):277-85. PubMed ID: 7911291
    [Abstract] [Full Text] [Related]

  • 9. Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity.
    Ness GC, Chambers CM, Lopez D.
    J Lipid Res; 1998 Jan 15; 39(1):75-84. PubMed ID: 9469588
    [Abstract] [Full Text] [Related]

  • 10. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
    Liang K, Kim CH, Vaziri ND.
    Am J Physiol Renal Physiol; 2005 Mar 15; 288(3):F539-44. PubMed ID: 15507547
    [Abstract] [Full Text] [Related]

  • 11. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity.
    Ness GC, Chambers CM.
    Proc Soc Exp Biol Med; 2000 May 15; 224(1):8-19. PubMed ID: 10782041
    [Abstract] [Full Text] [Related]

  • 12. Increased sensitivity to dietary cholesterol in diabetic and hypothyroid rats associated with low levels of hepatic HMG-CoA reductase expression.
    Ness GC, Gertz KR.
    Exp Biol Med (Maywood); 2004 May 15; 229(5):407-11. PubMed ID: 15096652
    [Abstract] [Full Text] [Related]

  • 13. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K, Vaziri ND.
    Kidney Int; 2003 Jul 15; 64(1):192-8. PubMed ID: 12787409
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver.
    Pallottini V, Montanari L, Cavallini G, Bergamini E, Gori Z, Trentalance A.
    Mech Ageing Dev; 2004 Sep 15; 125(9):633-9. PubMed ID: 15491682
    [Abstract] [Full Text] [Related]

  • 15. Regulation of rat liver cell 3-hydroxy-3-methylglutaryl coenzyme A reductase by methoxypolyoxyethylated cholesterol.
    Martin GG, Shapiro DJ.
    Biochim Biophys Acta; 1985 Nov 14; 837(2):163-72. PubMed ID: 4052444
    [Abstract] [Full Text] [Related]

  • 16. Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol.
    Ness GC, Gertz KR.
    Exp Biol Med (Maywood); 2004 May 14; 229(5):412-6. PubMed ID: 15096653
    [Abstract] [Full Text] [Related]

  • 17. Green and black tea extracts inhibit HMG-CoA reductase and activate AMP kinase to decrease cholesterol synthesis in hepatoma cells.
    Singh DK, Banerjee S, Porter TD.
    J Nutr Biochem; 2009 Oct 14; 20(10):816-22. PubMed ID: 18926682
    [Abstract] [Full Text] [Related]

  • 18. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.
    Kita T, Brown MS, Goldstein JL.
    J Clin Invest; 1980 Nov 14; 66(5):1094-100. PubMed ID: 6903572
    [Abstract] [Full Text] [Related]

  • 19. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
    Roberts CK, Liang K, Barnard RJ, Kim CH, Vaziri ND.
    Kidney Int; 2004 Oct 14; 66(4):1503-11. PubMed ID: 15458444
    [Abstract] [Full Text] [Related]

  • 20. Induction of hepatic cyclooxygenase-2 by hyperhomocysteinemia via nuclear factor-kappaB activation.
    Wu N, Siow YL, O K.
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct 14; 297(4):R1086-94. PubMed ID: 19657099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.